Literature DB >> 9446822

Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues.

M R D'Andrea1, C K Derian, D Leturcq, S M Baker, A Brunmark, P Ling, A L Darrow, R J Santulli, L F Brass, P Andrade-Gordon.   

Abstract

PAR-2 is a second member of a novel family of G-protein-coupled receptors characterized by a proteolytic cleavage of the amino terminus, thus exposing a tethered peptide ligand that autoactivates the receptor. The physiological and/or pathological role(s) of PAR-2 are still unknown. This study provides tissue-specific cellular localization of PAR-2 in normal human tissues by immunohistochemical techniques. A polyclonal antibody, PAR-2C, was raised against a peptide corresponding to the amino terminal sequence SLIGKVDGTSHVTGKGV of human PAR-2. Significant PAR-2 immunoreactivity was detected in smooth muscle of vascular and nonvascular origin and stromal cells from a variety of tissues. PAR-2 was also present in endothelial and epithelial cells independent of tissue type. Strong immunolabeling was observed throughout the gastrointestinal tract, indicating a possible function for PAR-2 in this system. In the CNS, PAR-2 was localized to many astrocytes and neurons, suggesting involvement of PAR-2 in neuronal function. A role for PAR-2 in the skin was further supported by its immunolocalization in the epidermis. PAR-2C antibody exemplifies an important tool to address the physiological role(s) of PAR-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9446822     DOI: 10.1177/002215549804600204

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  73 in total

1.  Basolateral proteinase-activated receptor (PAR-2) induces chloride secretion in M-1 mouse renal cortical collecting duct cells.

Authors:  M Bertog; B Letz; W Kong; M Steinhoff; M A Higgins; A Bielfeld-Ackermann; E Frömter; N W Bunnett; C Korbmacher
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

2.  Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways.

Authors:  J M Chow; J D Moffatt; T M Cocks
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 3.  Protease activated receptor 2 and the cardiovascular system.

Authors:  Carla Cicala
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.

Authors:  Yoonjung Park; Jiyeon Yang; Hanrui Zhang; Xiaonai Chen; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2010-10-24       Impact factor: 17.165

Review 5.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

6.  Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion.

Authors:  A Lourbakos; J Potempa; J Travis; M R D'Andrea; P Andrade-Gordon; R Santulli; E J Mackie; R N Pike
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 7.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 8.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

9.  Effect of protease-activated receptor 2 activation on single TRPV1 channel activities in rat vagal pulmonary sensory neurons.

Authors:  Qihai Gu; Lu-Yuan Lee
Journal:  Exp Physiol       Date:  2009-05-08       Impact factor: 2.969

10.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.